US Stock MarketDetailed Quotes

Akebia Therapeutics (AKBA)

Watchlist
  • 1.405
  • +0.055+4.07%
Close Apr 17 16:00 ET
  • 1.401
  • -0.004-0.29%
Post 19:26 ET
376.37MMarket Cap-70.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics (AKBA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
47.46%236.2M
23.93%57.62M
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.70%160.18M
-17.26%46.5M
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
Operating revenue
47.46%236.2M
23.93%57.62M
57.01%58.77M
43.13%62.47M
75.84%57.34M
-17.70%160.18M
-17.26%46.5M
-10.98%37.43M
-22.58%43.65M
-18.49%32.61M
Cost of revenue
-37.54%39.46M
-38.45%12.54M
-33.74%9.38M
-41.81%9.92M
-34.30%7.63M
-14.80%63.18M
9.11%20.37M
-21.37%14.16M
-1.37%17.05M
-42.52%11.61M
Gross profit
102.81%196.73M
72.54%45.09M
112.24%49.38M
97.56%52.55M
136.70%49.71M
-19.48%97M
-30.37%26.13M
-3.20%23.27M
-31.95%26.6M
5.99%21M
Operating expense
17.51%173.24M
32.64%53.64M
25.61%44.93M
8.88%38.46M
0.88%36.2M
-11.49%147.42M
11.84%40.44M
-3.07%35.77M
-26.68%35.33M
-20.81%35.88M
Selling and administrative expenses
0.88%107.48M
-5.73%26.09M
9.72%29.09M
-1.34%26.56M
1.20%25.74M
6.30%106.55M
8.80%27.68M
16.76%26.52M
-0.44%26.92M
1.54%25.44M
Research and development costs
65.62%62.36M
126.10%26.65M
76.08%14.94M
44.02%11.01M
0.24%9.75M
-40.31%37.65M
19.47%11.79M
-36.33%8.49M
-62.14%7.65M
-50.57%9.73M
Other operating expenses
5.47%3.4M
-7.67%903K
16.51%896K
17.59%896K
-1.41%701K
-0.53%3.22M
14.25%978K
-11.00%769K
-19.70%762K
25.18%711K
Operating profit
146.61%23.5M
40.22%-8.55M
135.58%4.45M
261.48%14.09M
190.83%13.51M
-9.42%-50.41M
-1,141.27%-14.31M
2.81%-12.51M
4.02%-8.73M
41.63%-14.88M
Net non-operating interest income expense
-32.96%-24.18M
29.81%-4.83M
28.72%-4.75M
-218.01%-6.83M
-211.05%-7.77M
-201.48%-18.19M
-384.98%-6.88M
-372.41%-6.66M
-30.88%-2.15M
-60.03%-2.5M
Non-operating interest expense
32.96%24.18M
-29.81%4.83M
-28.72%4.75M
218.01%6.83M
211.05%7.77M
201.48%18.19M
384.98%6.88M
372.41%6.66M
30.88%2.15M
60.03%2.5M
Other net income (expense)
-274.97%-3.04M
232.41%2.15M
266.55%1.45M
-405.76%-7.01M
160.43%368K
-545.60%-811K
-346.20%-1.62M
-311.79%-873K
620.91%2.29M
-446.02%-609K
Gain on sale of security
-839.09%-3.1M
235.04%2.26M
271.03%1.46M
-399.44%-6.98M
220.16%155K
---330K
---1.68M
---856K
--2.33M
---129K
Special income (charges)
--0
--0
--0
--0
--0
18.44%-575K
--0
--0
--0
-442.45%-575K
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
-67.96%58K
--0
--0
--0
-45.28%58K
-Less:Other special charges
----
----
----
----
----
-1.34%517K
--0
----
----
--517K
Other non- operating income (expenses)
-38.30%58K
-312.73%-117K
41.18%-10K
28.21%-28K
124.21%213K
-89.40%94K
-91.64%55K
60.47%-17K
-290.00%-39K
-66.31%95K
Income before tax
94.64%-3.72M
50.73%-11.24M
105.76%1.16M
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
Income tax
1.62M
1.01M
615K
0
0
0
Net income
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
Net income continuous Operations
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
Minority interest income
Net income attributable to the parent company
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
92.30%-5.35M
46.31%-12.24M
102.69%540K
102.88%247K
133.98%6.11M
-33.67%-69.41M
-3,814.01%-22.8M
-38.30%-20.04M
23.18%-8.58M
33.08%-17.99M
Basic earnings per share
93.94%-0.02
50.00%-0.05
0
0
133.33%0.03
-17.86%-0.33
-3,197.89%-0.1
-25.00%-0.1
33.33%-0.04
40.00%-0.09
Diluted earnings per share
93.94%-0.02
50.00%-0.05
0
0
133.33%0.03
-17.86%-0.33
-3,207.52%-0.1
-25.00%-0.1
33.33%-0.04
40.00%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 47.46%236.2M23.93%57.62M57.01%58.77M43.13%62.47M75.84%57.34M-17.70%160.18M-17.26%46.5M-10.98%37.43M-22.58%43.65M-18.49%32.61M
Operating revenue 47.46%236.2M23.93%57.62M57.01%58.77M43.13%62.47M75.84%57.34M-17.70%160.18M-17.26%46.5M-10.98%37.43M-22.58%43.65M-18.49%32.61M
Cost of revenue -37.54%39.46M-38.45%12.54M-33.74%9.38M-41.81%9.92M-34.30%7.63M-14.80%63.18M9.11%20.37M-21.37%14.16M-1.37%17.05M-42.52%11.61M
Gross profit 102.81%196.73M72.54%45.09M112.24%49.38M97.56%52.55M136.70%49.71M-19.48%97M-30.37%26.13M-3.20%23.27M-31.95%26.6M5.99%21M
Operating expense 17.51%173.24M32.64%53.64M25.61%44.93M8.88%38.46M0.88%36.2M-11.49%147.42M11.84%40.44M-3.07%35.77M-26.68%35.33M-20.81%35.88M
Selling and administrative expenses 0.88%107.48M-5.73%26.09M9.72%29.09M-1.34%26.56M1.20%25.74M6.30%106.55M8.80%27.68M16.76%26.52M-0.44%26.92M1.54%25.44M
Research and development costs 65.62%62.36M126.10%26.65M76.08%14.94M44.02%11.01M0.24%9.75M-40.31%37.65M19.47%11.79M-36.33%8.49M-62.14%7.65M-50.57%9.73M
Other operating expenses 5.47%3.4M-7.67%903K16.51%896K17.59%896K-1.41%701K-0.53%3.22M14.25%978K-11.00%769K-19.70%762K25.18%711K
Operating profit 146.61%23.5M40.22%-8.55M135.58%4.45M261.48%14.09M190.83%13.51M-9.42%-50.41M-1,141.27%-14.31M2.81%-12.51M4.02%-8.73M41.63%-14.88M
Net non-operating interest income expense -32.96%-24.18M29.81%-4.83M28.72%-4.75M-218.01%-6.83M-211.05%-7.77M-201.48%-18.19M-384.98%-6.88M-372.41%-6.66M-30.88%-2.15M-60.03%-2.5M
Non-operating interest expense 32.96%24.18M-29.81%4.83M-28.72%4.75M218.01%6.83M211.05%7.77M201.48%18.19M384.98%6.88M372.41%6.66M30.88%2.15M60.03%2.5M
Other net income (expense) -274.97%-3.04M232.41%2.15M266.55%1.45M-405.76%-7.01M160.43%368K-545.60%-811K-346.20%-1.62M-311.79%-873K620.91%2.29M-446.02%-609K
Gain on sale of security -839.09%-3.1M235.04%2.26M271.03%1.46M-399.44%-6.98M220.16%155K---330K---1.68M---856K--2.33M---129K
Special income (charges) --0--0--0--0--018.44%-575K--0--0--0-442.45%-575K
-Less：Restructuring and merger&acquisition --0--0--0--0--0-67.96%58K--0--0--0-45.28%58K
-Less:Other special charges ---------------------1.34%517K--0----------517K
Other non- operating income (expenses) -38.30%58K-312.73%-117K41.18%-10K28.21%-28K124.21%213K-89.40%94K-91.64%55K60.47%-17K-290.00%-39K-66.31%95K
Income before tax 94.64%-3.72M50.73%-11.24M105.76%1.16M102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M
Income tax 1.62M1.01M615K000
Net income 92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M
Net income continuous Operations 92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M
Minority interest income
Net income attributable to the parent company 92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 92.30%-5.35M46.31%-12.24M102.69%540K102.88%247K133.98%6.11M-33.67%-69.41M-3,814.01%-22.8M-38.30%-20.04M23.18%-8.58M33.08%-17.99M
Basic earnings per share 93.94%-0.0250.00%-0.0500133.33%0.03-17.86%-0.33-3,197.89%-0.1-25.00%-0.133.33%-0.0440.00%-0.09
Diluted earnings per share 93.94%-0.0250.00%-0.0500133.33%0.03-17.86%-0.33-3,207.52%-0.1-25.00%-0.133.33%-0.0440.00%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -